Drug notes:
KYV-201 RD autoimmune diseases
About:
Kyverna Therapeutics is engineering cell therapies for autoimmune and inflammatory diseases. Many autoimmune diseases lack optimal treatment for patients. Through the use of synthetic biology, immunology and cell engineering, Kyverna is using their SmarTcell platform to advance technologies to treat the cause of these diseases. Kyverna’s technologies include chimeric antigen receptor T cells designed to eliminate pathogenic cells in specific organs and tissues. Kyverna is also developing synthetic versions of Regulatory T cells to control immune homeostasis. Current therapies are in clinical trials for B-cell driven autoimmune diseases.
Supply Chain CoordinatorSupply Chain Coordinator Emeryville, CA|8 days ago
Supply Chain CoordinatorSupply Chain Coordinator Emeryville, California|8 days ago
Associate Director, Regulatory Affairs, Advertisin...Associate Director, Regulatory... Remote|25 days ago
Manager of Regulatory Affairs, ConsultantManager of Regulatory Affairs,... Remote|28 days ago
Director, Marketing PromotionsDirector, Marketing Promotions... Remote|41 days ago
Vice President, MarketingVice President, Marketing Remote|48 days ago
Sr. Director, Safety & PharmacovigilanceSr. Director, Safety & Pha... Remote|56 days ago
Cell Therapy Account Management Specialist - Centr...Cell Therapy Account Managemen... Remote|68 days ago
Cell Therapy Account Management Specialist - Great...Cell Therapy Account Managemen... Remote|68 days ago
Cell Therapy Account Management Specialist - Mid-A...Cell Therapy Account Managemen... Remote|68 days ago
Cell Therapy Account Management Specialist - Pacif...Cell Therapy Account Managemen... Remote|68 days ago
Executive Director, Medical WritingExecutive Director, Medical Wr... Remote|98 days ago